133747-62-3

Basic information

• Product Name: Methyl 1-(4-fluorophenyl)-5-oxopyrrolidine-3-carboxylate
• Synonyms: Methyl 1-(4-fluorophenyl)-5-oxopyrrolidine-3-carboxylate
• CAS NO: 133747-62-3
• Molecular Formula: C₁₂H₁₂FNO₃
• Molecular Weight: 237.2269832
• Mol File: 133747-62-3.mol

Chemical Properties

• Melting Point: 101-102 °C(Solv: ethanol (64-17-5))
• Boiling Point: 422.1±40.0 °C(Predicted)
• Appearance: /
• Density: 1.301±0.06 g/cm3(Predicted)
• PKA: -0.77±0.40(Predicted)
• CAS DataBase Reference: Methyl 1-(4-fluorophenyl)-5-oxopyrrolidine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 1-(4-fluorophenyl)-5-oxopyrrolidine-3-carboxylate(133747-62-3)
• EPA Substance Registry System: Methyl 1-(4-fluorophenyl)-5-oxopyrrolidine-3-carboxylate(133747-62-3)

Safety Data

• Hazardous Substances Data: 133747-62-3(Hazardous Substances Data)

Upstream product

• 97-65-4 2-methylenesuccinic acid 
• 67-56-1 methanol 
• 1181406-58-5 C₁₁H₉ClFNO₂ 
• 56617-43-7 1-(4-fluorophenyl)-5-oxopyrrolidine-3-carboxylic acid 
• 371-40-4 4-fluoroaniline 

Downstream Products

• 133747-64-5 4-[1-(4-fluorophenyl)-5-oxo-pyrrolidin-3-ylmethoxy]benzoic acid methyl ester 
• 669696-68-8 1-(4-fluorophenyl)-4-hydrazinocarbonyl-2-pyrrolidinone 
• 133747-63-4 1-(4-fluorophenyl)-4-hydroxymethylpyrrolidin-2-one 

Relevant articles and documents

Cyclization products of N-fluorophenyl-β-alanines and their properties

Interaction of 2-and 4-fluorophenylamines with acrylic and itaconic acids leads to the synthesis of the corresponding N-substituted β-alanines, the cyclization of which leads to derivatives of dihydropyrimidinone, 4-carboxy-2-pyrrolidinone, and tetrahydro

The discovery of new plant activators and scaffolds with potential induced systemic resistance: From jasmonic acid to pyrrolidone

Plants can develop multifaceted system resistance as a result of infection with pathogens, insects, and some specific microbes or after treatment with specific chemicals.1 Among them, systemic acquired resistance (SAR) and induced systemic resi

CALCIUM RECEPTOR MODULATING AGENTS

The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula I.

Synthesis of 4-methyloxybenzoic acids and related compounds, and their inhibitory capacities toward fatty-acid and sterol biosynthesis

The synthesis of a series of 4-methyloxybenzoic acids and related compounds, and their evaluation for inhibitory capacity toward fatty-acid and sterol biosyntheses using rats' liver slices in vitro and rabbits